Osteoarthritis Trial, Recruiting NCT07301242 Sponsor: Shanghai Geriatric Medical Center Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07301242
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 65 years of age or older
  • People with a body weight that falls within a moderate, healthy range (a BMI between 18 and 30)
  • People whose overall physical health before surgery is rated as good to moderately managed (ASA classification I–III — confirm with trial site if unsure which category applies)
  • People who are already scheduled for a planned, non-emergency bone or joint surgery on a limb, to be performed under general anaesthesia
  • People whose surgery is expected to last longer than 30 minutes
  • People who are willing to take part and are able to sign a written consent form

Who may not be able to join:

  • People with a known allergy to ciprofol or similar medications, or any medical reason they cannot receive these medications
  • People who have signs of memory or thinking difficulties before surgery
  • People with a history of serious stroke or other significant blood vessel problems in the brain
  • People with a history of nerve, muscle, or psychiatric conditions
  • People with a history of regularly using sedative or calming medications
  • People with a history of alcohol misuse or drug use disorder
  • People with a slow heart rate (fewer than 60 beats per minute)
  • People with low blood pressure (mean arterial pressure below 55 mmHg)
  • People with a specific irregularity in heart rhythm known as QT interval prolongation (confirm with trial site)
  • People who are unable to cooperate or communicate effectively

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xue Zhang, Shanghai Geriatric Medical Center

Phone: 02164175590

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Geriatric Medical Center
Registry
ClinicalTrials.gov
Start date
28 October 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Plasma Concentration of Ciprofol; Bispectral Index (BIS) Value; Modified Observer's Assessment of Alertness/Sedation (MOAA/S) Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov